Role of Oncostatin M in Exercise-Induced Breast Cancer Prevention
Cancers · 31.07.2024 · 16 (15) · 2716
DOI: 10.3390/cancers16152716 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 31.07.2024. Verfasst von Kara A Negrini und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Comparative Medicine, College of Medicine, The Pennsylvania State University, Hershey, PA 17033, USA. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Moderate-to-vigorous-intensity physical activity decreases the risk of breast cancer. The muscle-derived cytokine (myokine), oncostatin M (OSM), has been shown to decrease breast cancer cell proliferation. We hypothesized that OSM is involved in physical activity-induced breast cancer prevention, and that OSM antibody (Anti-OSM) administration would mitigate the effect of physical activity in a rat model of mammary carcinoma. Female Sprague Dawley rats were injected with 50 mg/kg N-methyl-N-nitrosourea to induce mammary carcinogenesis. During the 20-week study, rats were exercise trained (EX) or remained sedentary (SED). Additional groups were treated with Anti-OSM antibody (SED + Anti-OSM and EX + Anti-OSM) to explore the impact of OSM blockade on tumor latency. Exercise training consisted of treadmill acclimation and progressive increases in session duration, speed, and grade, until reaching 30 min/day, 20 m/min at 15% incline. Experimentally naïve, age-matched, female rats also completed an acute exercise test (AET) with time course blood draws to evaluate OSM plasma concentrations. Relative tumor-free survival time was significantly longer in EX animals (1.36 ± 0.39) compared to SED animals (1.00 ± 0.17; p = 0.009), SED + Anti-OSM animals (0.90 ± 0.23; p = 0.019), and EX + Anti-OSM animals (0.93 ± 0.74; p = 0.004). There were no significant differences in relative tumor latency between SED, SED + Anti-OSM, or EX + Anti-OSM animals. Following the AET, OSM plasma levels trended higher compared to baseline OSM levels (p = 0.080). In conclusion, we observed that exercise-induced delay of mammary tumor development was mitigated through Anti-OSM administration. Thus, future studies of the OSM mechanism are required to lay the groundwork for developing novel chemo-prevention strategies in women who are unable or unwilling to exercise.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Comparative Medicine, College of Medicine, The Pennsylvania State University, Hershey, PA 17033, USA.
- Public Health Sciences, College of Medicine, The Pennsylvania State University, Hershey, PA 17033, USA.
- Department of Medicine, College of Medicine, The Pennsylvania State University, Hershey, PA 17033, USA.
- Department of Horticulture and Landscape Architecture, Colorado State University, Fort Collins, CO 80523, USA.
ORCID-Profile: Kara A Negrini, Henry J Thompson, Kathleen M Sturgeon
Zitieren
APA
Negrini, K. A., Lin, D., Shah, D., Wu, H., Wehrung, K. M., Thompson, H. J., Whitcomb, T., & Sturgeon, K. M. (2024). Role of Oncostatin M in Exercise-Induced Breast Cancer Prevention. Cancers, 16(15), 2716. https://doi.org/10.3390/cancers16152716
Vancouver
Negrini KA, Lin D, Shah D, Wu H, Wehrung KM, Thompson HJ, et al. Role of Oncostatin M in Exercise-Induced Breast Cancer Prevention. Cancers. 2024;16(15):2716. doi:10.3390/cancers16152716
BibTeX
@article{Negrini2024,
author = {Negrini, Kara A and Lin, Dan and Shah, Dhruvil and Wu, Hongke and Wehrung, Katherine M and Thompson, Henry J and Whitcomb, Tiffany and Sturgeon, Kathleen M},
title = {Role of Oncostatin M in Exercise-Induced Breast Cancer Prevention},
journal = {Cancers},
year = {2024},
volume = {16},
number = {15},
pages = {2716},
doi = {10.3390/cancers16152716}
}
EUVIMED